Attorneys: PDMA isn't broken, don't change it

Share this article:

Two Hyman, Phelps & McNamara attorneys have told the US Sentencing Commission that the guideline for misdemeanor offenses under the Prescription Drug Marketing Act isn't broken and shouldn't be changed. The FDA asked the commission to consider changing the guideline because its maximum prison term isn't enough.

Share this article:

Email Newsletters

More in Business Briefs

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.

Insurers get personal to nip costs

Healthcare insurers seek to curb diabetes costs with interventions that may include house calls.

Novartis dials down RNA research

The drugmaker says the therapeutic approach has a narrow treatment potential.